Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Evidences of plasma membrane-mediated ROS generation upon ELF exposure in neuroblastoma cells.

Merla C, Liberti M, Consales C, Denzi A, Apollonio F, Marino C, Benassi B.

Biochim Biophys Acta Biomembr. 2019 Jun 11. pii: S0005-2736(19)30137-3. doi: 10.1016/j.bbamem.2019.06.005. [Epub ahead of print]

PMID:
31199897
2.

50-Hz MF does not affect global DNA methylation of SH-SY5Y cells treated with the neurotoxin MPP.

Benassi B, Santangeli S, Merla C, Tarantini L, Bollati V, Butera A, Marino C, Consales C.

Bioelectromagnetics. 2019 Jan;40(1):33-41. doi: 10.1002/bem.22158. Epub 2018 Dec 7.

PMID:
30537234
3.

50-Hz magnetic field impairs the expression of iron-related genes in the in vitro SOD1G93A model of amyotrophic lateral sclerosis.

Consales C, Panatta M, Butera A, Filomeni G, Merla C, Carrì MT, Marino C, Benassi B.

Int J Radiat Biol. 2019 Mar;95(3):368-377. doi: 10.1080/09553002.2019.1552378. Epub 2019 Jan 4.

PMID:
30513241
4.

Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx].

Bonassi S, Prinzi G, Lamonaca P, Russo P, Paximadas I, Rasoni G, Rossi R, Ruggi M, Malandrino S, Sánchez-Flores M, Valdiglesias V, Benassi B, Pacchierotti F, Villani P, Panatta M, Cordelli E.

BMC Complement Altern Med. 2018 Jan 22;18(1):22. doi: 10.1186/s12906-018-2080-5.

5.

Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells.

Consales C, Cirotti C, Filomeni G, Panatta M, Butera A, Merla C, Lopresto V, Pinto R, Marino C, Benassi B.

Mol Neurobiol. 2018 Jul;55(7):5698-5714. doi: 10.1007/s12035-017-0791-0. Epub 2017 Oct 16.

PMID:
29039021
6.

The epigenetic component of the brain response to electromagnetic stimulation in Parkinson's Disease patients: A literature overview.

Consales C, Merla C, Marino C, Benassi B.

Bioelectromagnetics. 2018 Jan;39(1):3-14. doi: 10.1002/bem.22083. Epub 2017 Oct 9. Review.

PMID:
28990199
7.

A microdosimetry study for a realistic shaped nucleus.

Denzi A, Escobar JA, Nasta C, Merla C, Benassi B, Consales C, Apollonio F, Liberti M.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4189-4192. doi: 10.1109/EMBC.2016.7591650.

PMID:
28269206
8.

A Microdosimetric Study of Electropulsation on Multiple Realistically Shaped Cells: Effect of Neighbours.

Denzi A, Camera F, Merla C, Benassi B, Consales C, Paffi A, Apollonio F, Liberti M.

J Membr Biol. 2016 Oct;249(5):691-701. Epub 2016 Jun 18.

PMID:
27318672
9.

Transgenerational inheritance of enhanced susceptibility to radiation-induced medulloblastoma in newborn Ptch1⁺/⁻ mice after paternal irradiation.

Paris L, Giardullo P, Leonardi S, Tanno B, Meschini R, Cordelli E, Benassi B, Longobardi MG, Izzotti A, Pulliero A, Mancuso M, Pacchierotti F.

Oncotarget. 2015 Nov 3;6(34):36098-112. doi: 10.18632/oncotarget.5553.

10.

Extremely Low Frequency Magnetic Field (ELF-MF) Exposure Sensitizes SH-SY5Y Cells to the Pro-Parkinson's Disease Toxin MPP(.).

Benassi B, Filomeni G, Montagna C, Merla C, Lopresto V, Pinto R, Marino C, Consales C.

Mol Neurobiol. 2016 Aug;53(6):4247-4260. doi: 10.1007/s12035-015-9354-4. Epub 2015 Jul 30.

PMID:
26223801
11.

Identification of post-transcriptional regulatory networks during myeloblast-to-monocyte differentiation transition.

Fontemaggi G, Bellissimo T, Donzelli S, Iosue I, Benassi B, Bellotti G, Blandino G, Fazi F.

RNA Biol. 2015;12(7):690-700. doi: 10.1080/15476286.2015.1044194.

12.

USP2a alters chemotherapeutic response by modulating redox.

Benassi B, Marani M, Loda M, Blandino G.

Cell Death Dis. 2013 Sep 26;4:e812. doi: 10.1038/cddis.2013.289.

13.

A melanoma immune response signature including Human Leukocyte Antigen-E.

Tremante E, Ginebri A, Lo Monaco E, Benassi B, Frascione P, Grammatico P, Cappellacci S, Catricalà C, Arcelli D, Natali PG, Di Filippo F, Mottolese M, Visca P, Benevolo M, Giacomini P.

Pigment Cell Melanoma Res. 2014 Jan;27(1):103-12. doi: 10.1111/pcmr.12164. Epub 2013 Oct 9.

PMID:
24011128
14.

HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment.

Benzoubir N, Lejamtel C, Battaglia S, Testoni B, Benassi B, Gondeau C, Perrin-Cocon L, Desterke C, Thiers V, Samuel D, Levrero M, Bréchot C, Bourgeade MF.

J Hepatol. 2013 Dec;59(6):1160-8. doi: 10.1016/j.jhep.2013.07.036. Epub 2013 Aug 6.

PMID:
23928402
15.

Electromagnetic fields, oxidative stress, and neurodegeneration.

Consales C, Merla C, Marino C, Benassi B.

Int J Cell Biol. 2012;2012:683897. Epub 2012 Sep 9.

16.

Direct and delayed X-ray-induced DNA damage in male mouse germ cells.

Cordelli E, Eleuteri P, Grollino MG, Benassi B, Blandino G, Bartoleschi C, Pardini MC, Di Caprio EV, Spanò M, Pacchierotti F, Villani P.

Environ Mol Mutagen. 2012 Jul;53(6):429-39. doi: 10.1002/em.21703. Epub 2012 Jun 22.

PMID:
22730201
17.

MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.

Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, Marani M, Strano S, Muti P, Blandino G, Loda M.

Cancer Discov. 2012 Mar;2(3):236-47. doi: 10.1158/2159-8290.CD-11-0219. Epub 2012 Jan 5.

18.

Omics underpins novel clues on VDR chemoprevention target in breast cancer.

Muti P, Benassi B, Falvo E, Santoro R, Galanti S, Citro G, Carrubba G, Blandino G, Strano S.

OMICS. 2011 Jun;15(6):337-46. doi: 10.1089/omi.2010.0086. Epub 2011 Feb 24. Review.

PMID:
21348760
19.

Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo.

Slee EA, Benassi B, Goldin R, Zhong S, Ratnayaka I, Blandino G, Lu X.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19479-84. doi: 10.1073/pnas.1005165107. Epub 2010 Oct 20.

20.

Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation.

Bruno T, Desantis A, Bossi G, Di Agostino S, Sorino C, De Nicola F, Iezzi S, Franchitto A, Benassi B, Galanti S, La Rosa F, Floridi A, Bellacosa A, Passananti C, Blandino G, Fanciulli M.

Cancer Cell. 2010 Aug 9;18(2):122-34. doi: 10.1016/j.ccr.2010.05.027.

21.

The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice.

Di Certo MG, Corbi N, Strimpakos G, Onori A, Luvisetto S, Severini C, Guglielmotti A, Batassa EM, Pisani C, Floridi A, Benassi B, Fanciulli M, Magrelli A, Mattei E, Passananti C.

Hum Mol Genet. 2010 Mar 1;19(5):752-60. doi: 10.1093/hmg/ddp539. Epub 2009 Dec 4.

PMID:
19965907
22.

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.

Ciuffreda L, Del Bufalo D, Desideri M, Di Sanza C, Stoppacciaro A, Ricciardi MR, Chiaretti S, Tavolaro S, Benassi B, Bellacosa A, Foà R, Tafuri A, Cognetti F, Anichini A, Zupi G, Milella M.

Neoplasia. 2009 Aug;11(8):720-31.

23.

Tetraploidy triggers mitochondria.

Benassi B, Strano S, Blandino G.

Cell Cycle. 2009 May 1;8(9):1305-6. No abstract available.

PMID:
19377300
24.

Cytokinesis-block micronucleus cytome assays for the determination of genotoxicity and cytotoxicity of cecal water in rats and fecal water in humans.

Benassi B, Leleu R, Bird T, Clifton P, Fenech M.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2676-80.

25.

Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells.

Benassi B, Zupi G, Biroccio A.

Mol Pharmacol. 2007 Oct;72(4):1015-23. Epub 2007 Jul 12.

PMID:
17628013
26.

The isopeptidase USP2a protects human prostate cancer from apoptosis.

Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M.

Cancer Res. 2006 Sep 1;66(17):8625-32.

27.

TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells.

Biroccio A, Rizzo A, Elli R, Koering CE, Belleville A, Benassi B, Leonetti C, Stevens MF, D'Incalci M, Zupi G, Gilson E.

Eur J Cancer. 2006 Aug;42(12):1881-8. Epub 2006 Jun 5.

PMID:
16750909
28.

c-Myc phosphorylation is required for cellular response to oxidative stress.

Benassi B, Fanciulli M, Fiorentino F, Porrello A, Chiorino G, Loda M, Zupi G, Biroccio A.

Mol Cell. 2006 Feb 17;21(4):509-19.

29.

Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.

Leonetti C, Amodei S, D'Angelo C, Rizzo A, Benassi B, Antonelli A, Elli R, Stevens MF, D'Incalci M, Zupi G, Biroccio A.

Mol Pharmacol. 2004 Nov;66(5):1138-46. Epub 2004 Aug 10.

PMID:
15304549
30.

Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents.

Biroccio A, Benassi B, Fiorentino F, Zupi G.

Neoplasia. 2004 May-Jun;6(3):195-206.

31.

Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis.

Biroccio A, Amodei S, Antonelli A, Benassi B, Zupi G.

J Biol Chem. 2003 Sep 12;278(37):35693-701. Epub 2003 Jun 24.

32.

Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.

Biroccio A, Gabellini C, Amodei S, Benassi B, Del Bufalo D, Elli R, Antonelli A, D'Incalci M, Zupi G.

Mol Pharmacol. 2003 Mar;63(3):632-8.

PMID:
12606771
33.

Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb.

Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N, Libri V, Benassi B, Mattei E, Chersi A, Soddu S, Floridi A, Passananti C, Fanciulli M.

Cancer Cell. 2002 Nov;2(5):387-99.

34.

Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells.

Biroccio A, Benassi B, Filomeni G, Amodei S, Marchini S, Chiorino G, Rotilio G, Zupi G, Ciriolo MR.

J Biol Chem. 2002 Nov 15;277(46):43763-70. Epub 2002 Sep 10.

35.

Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.

Biroccio A, Amodei S, Benassi B, Scarsella M, Cianciulli A, Mottolese M, Del Bufalo D, Leonetti C, Zupi G.

Oncogene. 2002 May 2;21(19):3011-9.

36.

Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line.

Leonetti C, Biroccio A, Benassi B, Stringaro A, Stoppacciaro A, Semple SC, Zupi G.

Cancer Gene Ther. 2001 Jun;8(6):459-68.

37.

c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.

Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G.

Mol Pharmacol. 2001 Jul;60(1):174-82.

PMID:
11408612
38.

c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Biroccio A, Benassi B, D'Agnano I, D'Angelo C, Buglioni S, Mottolese M, Ricciotti A, Citro G, Cosimelli M, Ramsay RG, Calabretta B, Zupi G.

Am J Pathol. 2001 Apr;158(4):1289-99.

39.

Medical treatment of senile cataract: clinical investigation of bendazac-lysine using objective and subjective methods.

Baraldi P, Fonda S, Toschi P, Benassi B, Luppi ML, Penne A, Mazza C, Bocca E.

Graefes Arch Clin Exp Ophthalmol. 1990;228(2):105-11.

PMID:
2338248
40.

Behavioral strategies for a deaf and cerebral palsied child.

Benassi BJ, Benassi VA.

J Commun Disord. 1973 Sep;6(3):165-74. No abstract available.

PMID:
4776553
41.

An approach to teaching behavior modification principles to parents.

Benassi VA, Benassi BJ.

Rehabil Lit. 1973 May;34(5):134-7. No abstract available.

PMID:
4700935

Supplemental Content

Loading ...
Support Center